StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly u.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M)

U.S. Bureau of Economic Analysis via FRED (DHLCRC1Q027SBEA)

Latest, Q2 2026
3,790
Period ended Jun 30, 2026
Change on a year earlier
+7.4%
3,530 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
1
FRED (DHLCRC1Q027SBEA)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M)Year on yearSource
Q2 2026Jun 30, 20263,790+7.4%FRED (DHLCRC1Q027SBEA) ↗
Q1 2026Mar 31, 20263,700+6.8%FRED (DHLCRC1Q027SBEA) ↗
Q4 2025Dec 31, 20253,667+7.3%FRED (DHLCRC1Q027SBEA) ↗
Q3 2025Sep 30, 20253,615+7.6%FRED (DHLCRC1Q027SBEA) ↗
Q2 2025Jun 30, 20253,530+7.3%FRED (DHLCRC1Q027SBEA) ↗
Q1 2025Mar 31, 20253,465+6.8%FRED (DHLCRC1Q027SBEA) ↗
Q4 2024Dec 31, 20243,418+8.2%FRED (DHLCRC1Q027SBEA) ↗
Q3 2024Sep 30, 20243,358+9.1%FRED (DHLCRC1Q027SBEA) ↗
Q2 2024Jun 30, 20243,288+8.3%FRED (DHLCRC1Q027SBEA) ↗
Q1 2024Mar 31, 20243,244+8.8%FRED (DHLCRC1Q027SBEA) ↗
Q4 2023Dec 31, 20233,159+8.7%FRED (DHLCRC1Q027SBEA) ↗
Q3 2023Sep 30, 20233,079+8.4%FRED (DHLCRC1Q027SBEA) ↗
Q2 2023Jun 30, 20233,035+9.5%FRED (DHLCRC1Q027SBEA) ↗
Q1 2023Mar 31, 20232,983+8.3%FRED (DHLCRC1Q027SBEA) ↗
Q4 2022Dec 31, 20222,907+6.5%FRED (DHLCRC1Q027SBEA) ↗
Q3 2022Sep 30, 20222,839+5.9%FRED (DHLCRC1Q027SBEA) ↗

Cite this data

StockData. (2026). Eli Lilly U.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fred_pce_healthcare_saar

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.